Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NSCLC-specific marrow-infiltrating lymphocytes

A preparation of autologous, ex-vivo activated and expanded, bone marrow-derived infiltrating lymphocytes (MILs) from a non-small cell lung cancer (NSCLC) patient, with potential antineoplastic and immunomodulating activities. Upon administration of the NSCLC-specific MILs, the T cells target and destroy the destroy the patient’s NSCLC cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	Marrow Infiltrating Lymphocytes-Non-Small Cell Lung Cancer MILs-NSCLC NSCLC-specific MILs

NSCLC-specific marrow-infiltrating lymphocytes

Search NCI's Drug Dictionary